Excitingly, in myasthenia [gravis], we have entered the advanced therapy era with the approval of the complement inhibitors starting in 2017, and now, more recently, the FcRn [neonatal Fc receptor ...
1 Department of Neurology, Affiliated Hospital of Yangzhou University, Yangzhou, China 2 Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China Myasthenia gravis (MG ... An ...
Myasthenia gravis (MG) does not have stages but classes ... A person may also experience eye muscle weakness. Class 3 There is moderate weakness in muscles other than around the eyes.
Kyle Rowe, managing director at Boots Opticians, said: “We’re delighted to bring optomap’s ultra-wide eye scans to Boots Opticians customers. This innovative technology not only gives patients a more ...
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years ... There are two types of autoimmune MG: ocular and generalised. Ocular MG causes weakness of the ...
This initiative bridges the gap by developing advanced AI tools to analyze images from calcium-scoring computed tomography (CT) scans, a widely used diagnostic tool. The scans, which indicate how ...
This new method could transform stroke prediction in primary care settings by using simple eye imaging to replace invasive tests. Researchers have developed a retinal ‘vascular fingerprint’ that can ...
Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, China Introduction: Efgartigimod has been approved for the treatment of acetylcholine receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results